Suchergebnisse - "McGregor, Kimberly"

PubPharm (46)

1

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Christopoulos, P. | Harel, M. | McGregor, K. | +34

2

The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2024

von Jin, W. | Zhang, L. | Graf, R. | +11

3

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

enthalten in: ResearchSquare.com | 2023

von Nielsen, T. | Varga, M. | Cronister, C. | +5

4

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

enthalten in: NPJ precision oncology | 2023

von Tung, N. | Dougherty, K. | Gatof, E. | +7

5

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Nielsen, T. | Varga, M. | Cronister, C. | +5

6

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer

enthalten in: NPJ breast cancer | 2023

von Page, D. | Pucilowska, J. | Chun, B. | +25

7

An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Antoniotti, C. | Boccaccino, A. | Seitz, R. | +22

8

METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES

enthalten in: Europäisches Patentamt | 2023

von DOUGHERTY KALI CHATHAM | GORNSTEIN ERICA | MCGREGOR KIMBERLY | +2

9

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

enthalten in: Cancer immunology immunotherapy | 2023

von Nielsen, T. | Varga, M. | Cronister, C. | +5

10

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

enthalten in: Cancer immunology immunotherapy | 2023

von Nielsen, T. | Varga, M. | Cronister, C. | +5

1
2
3
4
5
Nächster »
[5]